Vanguard reports 0 shares of Dolby (common stock)
The Vanguard Group filed Amendment No. 14 to a Schedule 13G/A reporting Dolby Laboratories Inc. common stock and states it beneficially owns 0 shares representing 0% of the class.
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 14 to a Schedule 13G/A reporting Dolby Laboratories Inc. common stock and states it beneficially owns 0 shares representing 0% of the class.
The filing explains an internal realignment effective January 12, 2026, that disaggregated certain Vanguard subsidiaries and business divisions for reporting under SEC Release No. 34-39538; the filing is signed by Ashley Grim, Head of Global Fund Administration.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial ownership after internal realignment and disaggregation.
The amendment shows 0 shares and 0% ownership in Dolby Laboratories Inc., reflecting that Vanguard's subsidiaries now report separately under SEC Release No. 34-39538 following a January 12, 2026 realignment.
Cash‑flow treatment or subsequent trading intentions are not stated; subsequent filings by the listed subsidiaries may disclose holdings separately.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why does the Schedule 13G/A amendment show zero ownership for Vanguard?
Who signed the Schedule 13G/A amendment for Vanguard?
Does this filing indicate any change in voting or dispositive power?
AI-generated analysis. How Rhea-AI works. Not financial advice.